SEZ13
SEZ13 is a Hedgehog pathway inhibitor. SEZ13 binds to the orthosteric pocket of Smoothened and inhibits Hedgehog signaling, reducing the expression of glioma-associated oncogene and patched, thereby inducing apoptosis (apoptosis) and G2/M phase cell cycle arrest, inhibiting cell migration and invasion, and exhibiting antiproliferative activity against colorectal cancer cells, with selectivity for normal endothelial cells and colonic epithelial cells. SEZ13 can be used for research on colon cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C18H21N7OS
- 분자량:383.47
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| NIH3T3 | IC50 |
19 nM
|
Inhibition of Gli-driven Hedgehog pathway reporter activity in NIH3T3 cells incubated 48 hrs by dual-luciferase assay.
Inhibition of Gli-driven Hedgehog pathway reporter activity in NIH3T3 cells incubated 48 hrs by dual-luciferase assay.
|
42892154 |
| HCT-116 | IC50 |
21.25 μM
|
Cytotoxicity against human HCT116 colorectal cancer cells assessed as viability reduction after 48 hrs by MTT assay.
Cytotoxicity against human HCT116 colorectal cancer cells assessed as viability reduction after 48 hrs by MTT assay.
|
42892154 |
| HT-29 | IC50 |
21.36 μM
|
Cytotoxicity against human HT-29 colorectal cancer cells assessed as viability reduction after 48 hrs by MTT assay.
Cytotoxicity against human HT-29 colorectal cancer cells assessed as viability reduction after 48 hrs by MTT assay.
|
42892154 |
| HUVEC | IC50 |
51.78 μM
|
Cytotoxicity against human umbilical vein endothelial HUVEC cells assessed as viability reduction after 48 hrs by MTT assay.
Cytotoxicity against human umbilical vein endothelial HUVEC cells assessed as viability reduction after 48 hrs by MTT assay.
|
42892154 |
| NCM460 | IC50 |
62.16 μM
|
Cytotoxicity against human NCM460 colon epithelial cells assessed as viability reduction after 48 hrs by MTT assay.
Cytotoxicity against human NCM460 colon epithelial cells assessed as viability reduction after 48 hrs by MTT assay.
|
42892154 |
In Vitro
SEZ13 (10-30 μM; 24-48 h) dose-dependently reduces wound closure in HCT116 and HT-29 cells[1].
SEZ13 (10-30 μM; 48 h) dose-dependently inhibits Transwell migration of HCT116 and HT-29 cells[1].
SEZ13 (10-30 μM; 48 h) dose-dependently inhibits the invasion of HCT116 and HT-29 cells through Matrigel[1].
SEZ13 (10-30 μM; 48 h) downregulates Gli1 and Ptch1 mRNA in HCT116 and HT-29 cells, and co-exposure with Pur attenuates Pur-induced upregulation of Ptch1 and Gli1[1].
SEZ13 (10-30 μM; 48 h) downregulates Gli1 protein in HCT116 and HT-29 cells at 10 and 30 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT116 and HT-29 cells
-
Concentration:10, 20, and 30 μM
-
Incubation Time:24 h (Methods); 48 h (Results)
-
Result:Reduced wound closure in both HCT116 and HT-29 cells in a dose-dependent manner; 20 μM was the lowest concentration reported to inhibit migration, and 30 μM produced greater inhibition of HCT116 migration than Vismodegib.
-
Cell Line:HCT116 and HT-29 cells
-
Concentration:10, 20, and 30 μM
-
Incubation Time:48 h
-
Result:Reduced migration toward the lower chamber in a dose-dependent manner; 20 μM was the lowest concentration reported to inhibit migration in both cell lines, and at 30 μM the inhibitory effect on migration was more potent than Vismodegib.
-
Cell Line:HCT116 and HT-29 cells
-
Concentration:10, 20, and 30 μM
-
Incubation Time:48 h
-
Result:Inhibited invasion of both HCT116 and HT-29 cells in a dose-dependent manner; 20 μM was the lowest concentration reported to inhibit invasion, and at 30 μM the inhibitory effect was more pronounced than that of Vismodegib at the equivalent concentration.
-
Cell Line:HCT116 and HT-29 cells
-
Concentration:10 and 30 μM
-
Incubation Time:24 h (Methods); 48 h (Results)
-
Result:At 30 μM, induced apoptosis with apoptotic rates of 34.47% in HT-29 cells and 38.4% in HCT116 cells; at the same concentration, the pro-apoptotic effect was more pronounced than that of Vismodegib.
-
Cell Line:HCT116 and HT-29 cells
-
Concentration:10 and 30 μM
-
Incubation Time:24 h (Methods); 48 h (Results)
-
Result:Caused dose-dependent G2/M arrest.
In HT-29 cells, 10 μM gave G0/G1 87.32%, S 4.61%, and G2/M 8.07%; 30 μM gave G0/G1 84.34%, S 4.46%, and G2/M 11.20%.
In HCT116 cells, 10 μM gave G0/G1 63.33%, S 7.85%, and G2/M 28.82%; 30 μM gave G0/G1 54.47%, S 8.83%, and G2/M 36.70%.
-
Cell Line:HCT116 and HT-29 cells
-
Concentration:10, 20, and 30 μM (alone); 10, 20, and 30 μM (with Pur)
-
Incubation Time:48 h
-
Result:Reduced Ptch1 and Gli1 mRNA expression in both HT-29 and HCT116 cells.
Pur alone upregulated Ptch1 and Gli1 mRNA, while co-exposure attenuated the Pur-induced upregulation in a dose-dependent manner at 10, 20, and 30 μM.
-
Cell Line:HCT116 and HT-29 cells
-
Concentration:10 and 30 μM
-
Incubation Time:48 h
-
Result:Reduced Gli1 protein expression in both HT-29 and HCT116 cells, with lower Gli1 levels at 30 μM than at 10 μM.
- RNA extraction experimental
- Scratch/Wound-Healing Migration Assay
- Annexin V plus membrane-impermeant dye apoptosis staining
- BrdU Incorporation Assay
- Cell migration
- Neural Crest/Neuronal Cell Migration Explant Assay
- Protocol for Cell Cycle
- Cell Viability Determination by MTT Colorimetric Assay
- Detection of Apoptosis
- TUNEL staining for apoptotic DNA fragmentation
- Flow cytometric DNA-content cell-cycle staining
- Zigmond Chamber Chemotaxis Assay
- Under-Agarose Cell Migration Assay
- Transwell/Boyden Chamber Migration Assay
- Endothelial Tube Formation Assay
- Apoptosis Solutions
- 3D Collagen/Hydrogel Matrix Migration Assay
- Cell invasion
- Cell-Exclusion Zone Migration Assay
- Dunn/Insall Chamber Chemotaxis Assay
Chemical Information
-
분자량 383.47
-
화학식 C18H21N7OS
-
SMILES
O=C(CCC1=CC=CN=C1)N2CCN(C3=NN=C(C4=CN(C)N=C4)S3)CC2
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)